Kepivance (palifermin) made by Amgen is the only drug approved by FDA in 2004 to treat severe OM and ONLY for patients undergoing bone marrow transplants in hematologic malignancies ( blood cancers ).
(2)
(0)
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
